Inventor
KUCHIMANCHI SATYANARAYANA
US39 patents
⚠️ This page may combine multiple inventors who share the name “KUCHIMANCHI SATYANARAYANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
26 patentsUS9796974B2Oct 24, 2017
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC119 citations99
US9399775B2Jul 26, 2016
RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
ALNYLAM PHARMACEUTICALS INC51 citations98
US10668170B2Jun 2, 2020
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC22 citations94
US9249415B2Feb 2, 2016
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC24 citations94
US9850488B2Dec 26, 2017
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC11 citations92
US11406716B2Aug 9, 2022
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC8 citations86
US10570391B2Feb 25, 2020
RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
ALNYLAM PHARMACEUTICALS INC12 citations86
US11142766B2Oct 12, 2021
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC4 citations84
US11034958B2Jun 15, 2021
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC7 citations84
US10407679B2Sep 10, 2019
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC5 citations84
US10238749B2Mar 26, 2019
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC12 citations84
US10125369B2Nov 13, 2018
PCSK9 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC9 citations84
US9701963B2Jul 11, 2017
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC9 citations84
US9376680B2Jun 28, 2016
Serpinc1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC7 citations84
US11873491B2Jan 16, 2024
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US11419942B2Aug 23, 2022
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US11408001B1Aug 9, 2022
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC1 citations73
US11162098B2Nov 2, 2021
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US10814007B2Oct 27, 2020
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC3 citations73
US9970006B2May 15, 2018
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
ALNYLAM PHARMACEUTICALS INC4 citations73
US9725718B2Aug 8, 2017
Compositions and methods for inhibition of expression of protein C (PROC) genes
ALNYLAM PHARMACEUTICALS INC3 citations73
US12590305B2Mar 31, 2026
Complement component C5 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC0 citations62
US12460206B2Nov 4, 2025
PCSK9 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC0 citations62
US12290573B2May 6, 2025
Modified RNAi agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US11118181B2Sep 14, 2021
Compositions and methods for inhibition of expression of protein C (PROC) genes
ALNYLAM PHARMACEUTICALS INC0 citations62
US10273478B2Apr 30, 2019
Compositions and methods for inhibition of expression of protein C (PROC) genes
ALNYLAM PHARMACEUTICALS INC0 citations52
ARROWHEAD PHARMACEUTICALS INC
3 patentsUS10287582B2May 14, 2019
Organic compositions to treat HSF1-related diseases
ARROWHEAD PHARMACEUTICALS INC3 citations83
US12091661B2Sep 17, 2024
Organic compositions to treat HSF1-related diseases
ARROWHEAD PHARMACEUTICALS INC0 citations62
US11091761B2Aug 17, 2021
Organic compositions to treat HSF1-related diseases
ARROWHEAD PHARMACEUTICALS INC0 citations62
ARROWHEAD RES CORP
2 patentsBETTENCOURT BRIAN
2 patentsUS9228188B2Jan 5, 2016
Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
BETTENCOURT BRIAN8 citations82
US9315813B2Apr 19, 2016
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
BETTENCOURT BRIAN3 citations71